Steering Committee
Dr. Anna van Poucke
Global Head of Healthcare KPMG International, Healthcare Senior Partner KPMG, the Netherlands
Dr. Anna van Poucke
As Global Head of Healthcare, Anna leads the KPMG healthcare network of 5,000 professionals who provide Audit, Tax and Advisory services to healthcare organizations in more than 70 countries and territories around the world.
Anna is a trusted advisor to health leaders ranging from ministers of health, hospital CEOs and executives of payor organizations across six continents. She draws on more than 30 years of experience in diverse senior managerial, board, and consultancy roles in the sector. She understands the complex nature of the sector and brings not only a bold vision for the future of health but also the experience to execute on transformation initiatives.
Anna is the author of several KPMG International publications on topics that include future scenario’s for healthcare systems, organizational transformation, health equity, sustainability and resilience, value-based healthcare, out of hospital care provision, and technology-enabled care delivery systems. She is a well-regarded keynote speaker at international events covering topics that include healthcare system effectiveness and resilience, digital transformation and health equity. Anna sits on the Steering Committee for the Partnership for Health System Sustainability and Resilience, a global collaboration between the World Economic Forum, the London School of Economics, AstraZeneca, Royal Philips, KPMG, Apollo Hospitals and the Center for Asia-Pacific Resilience and Innovation.
Prior to her appointment as Global Head in 2020, Anna was Head of Healthcare for KPMG in the Netherlands, where she founded and grew the firm’s healthcare advisory business. In this role, she supervised a number of successful national and regional transformation programs based on design and implementation of new service delivery, reimbursement and governance models and physical infrastructures. Anna was also global lead for KPMG’s Care System Redesign proposition group, in this capacity she worked extensively with clients to transform and help futureproof care systems.
Before joining KPMG in 2011, Anna held senior-level positions at several hospitals and academic health sciences centers, where she led and executed transformations. As CEO of the Dutch Diagnosis Related-Groups (DRGs) and Pricing Office, Anna was a major force behind the adoption of DRG systems for providers and the introduction of a new national healthcare payment system.
Anna has a PhD in Economic Sciences from Erasmus University Rotterdam. She is fluent in English, French, German and Dutch.
Work Experience
- Global Sector Head of Healthcare, KPMG International (2020 – Present)
- Responsible for a team of 5,000 FTE professionals in the healthcare sector across 70 countries:
- Growing the business from $1.2 Bio in FY21 to $1.8Bio in FY24
- Standing up and deploying a global digital health hub; a model that is replicated and considered best practice in the firm
- Establishing a strong alliance strategy leading to ‘ global industry partner of the year awards’ (Service Now) and the selection as the preferred partner for the role out and implementation of leading new Microsoft tooling
- Senior Advisor/Subject Matter Expert to Ministers of Health and senior leaders from health systems, insurers and leading tech companies across 6 continents
- Prolific author with several publications and renowned keynote speaker at high-level international conferences
- Responsible for a team of 5,000 FTE professionals in the healthcare sector across 70 countries:
- Sector Lead, KPMG Health Netherlands & Partner, KPMG NL (2013 – 2020)
- Global Lead, Healthcare System Redesign, KPMG International (2013 – 2020)
- Member of the Extended Board of Management, KPMG Netherlands, KPMG Netherlands (2018 – 2019)
- Led the development of the Outlook 2025 Strategy for KPMG Netherlands aligned with KPMG Global GSP plan
- Chair, Partner and Director Admission Committee, KPMG Netherlands (2015 – 2018)
- Sector Lead, Hospitals; Proposition Lead, Healthcare System Redesign Netherlands; Director, HR Partner, KPMG Plexus (55 FTE), KPMG Netherlands (2011 – 2013)
- CEO/COO, Dutch DRG- and Pricing Office for Healthcare, DBC-Onderhoud (2006 – 2010)
- Led the development and implementation of national DRG and reimbursement systems for Medical Specialist Care and Mental Health Care
- Interim Management and Consultancy, Van Poucke (1998 – 2006)
- Manager, Consultancy Unit Academic Medical Science Centre; Program Director, Merger & Integration, Academic Medical Science Centre/National Children’s Hospital, UMCU (1995 – 1998)
- Product Manager, ‘Managing for Results’; (Senior) Consultant, GITP/Management Advies (1987 – 1995)
Education
- PhD, Radical Innovation in Knowledge-Intensive Service Firms, Erasmus University Rotterdam (1998 – 2005)
- Master’s in Economic Sciences, University College Cardiff (1985 – 1987)
- Master’s in Organisational Psychology, Katholieke Universiteit Brabant (1980 – 1985)
Extracurricular Board and Advisory roles
- Non-executive Board Member, Dutch Patient Federation, 2024 – Present
- Co-chair Steering Committee Hospital C-suite summit
- Member of the Advisory Board
- Member, Steering Committee, Partnership Program Health System Sustainability and Resilience (WEF, LSE, AstraZeneca, Philips, WHO Foundation), 2022 – 2025
- Vice-Chair/Non-executive Board Member, Patient Representative Organization for Cardiovascular Diseases, 2000 – 2009
- Vice-Chair, ‘Samen Verder’, Patient Representative Organization for CVA-Patients, 1998 – 2000
- Non-executive Board Member, Mental Health Hospital Wolfheze, 1991 – 1995
Prof. Eyal Zimlichman
Chief Transformation Officer and Chief Innovation Officer, Sheba Medical Center, Director and Founder, ARC Innovation, Israel
Prof. Eyal Zimlichman
Prof. Eyal Zimlichman is an internal medicine physician, healthcare executive, and researcher specializing in healthcare quality and value, patient engagement, and patient safety.
As Chief Transformation Officer, Chief Innovation Officer, and Chief AI Officer at Sheba Medical Center—Israel’s largest hospital—Prof. Zimlichman leads strategic transformation efforts to redesign healthcare, making it more patient-centered, efficient, effective, and equitable. To drive this vision forward, he founded ARC (Accelerate, Redesign, Collaborate), Sheba’s global innovation platform, which fosters collaboration between healthcare institutions, industry, and startups to advance digital health and AI-driven solutions.
His leadership in healthcare transformation has earned him international recognition, including being named one of the Chief Transformation Officers to Know in 2023 and 2024 by Becker’s Hospital Review.
Before assuming his current role, Prof. Zimlichman served as Sheba’s Chief Medical Officer and, prior to that, as Chief Quality Officer.
Prior to his tenure at Sheba, he was a Lead Researcher at Partners HealthCare’s Clinical Affairs Department in Boston, where he played a key role in strategic care redesign initiatives. There, he established a pioneering program for collecting and reporting patient-reported outcomes across the continuum of care—an initiative that received international recognition. During this time, he was also affiliated with Brigham and Women’s Hospital and the Harvard Medical School-affiliated Center for Patient Safety Research and Practice, where he conducted research on leveraging technology to enhance quality and patient safety.
Prof. Zimlichman is a founding member of the International Academy of Quality and Safety in Health Care and an International Expert at the International Society of Quality in Healthcare (ISQua). He has also served as an advisor to the Office of the National Coordinator for Health Information Technology at the U.S. Department of Health and Human Services.
In 2007, he was selected as a member of Sheba’s Talpiot Medical Leadership Program, designed to cultivate the next generation of physician leaders. A decade later, in 2017, he was appointed as the program’s director.
Prof. Zimlichman holds a Master of Science in Healthcare Management from the Harvard School of Public Health and earned his MD from the Technion – Israel Institute of Technology.
Prof. Luciano Ravera
Chief Executive Officer, Humanitas San Pio X and Humanitas Research Hospital
Prof. Luciano Ravera
Luciano Ravera is the Chief Executive Officer of the Humanitas Group since 2022.
He holds a degree in Economics with honors from Bocconi University in Milan and an MBA from Harvard Business School.
He joined the Techint Group (of which Humanitas is a part) in 1994, following prior professional experience at Barclays Bank and the management consulting firm Booz Allen & Hamilton.
He quickly advanced through positions of increasing responsibility, including Operations Manager at Humanitas Research Hospital, General Manager of Humanitas Gavazzeni in Bergamo (1999) and of Humanitas Research Hospital (2002). In 2005, he was appointed Director of Strategic Planning and Business Development of the Humanitas Group, and in 2007, he became Chief Executive Officer of Humanitas Mater Domini in Castellanza (Varese).
He was appointed CEO of Humanitas Research Hospital in 2009 and later of Humanitas San Pio X in Milan in 2020.
In 2022, he was entrusted with the overall leadership of the Group as CEO of Humanitas S.p.A., driving its continued development as an integrated system of clinical excellence, advanced research, and medical education.
Prof. Dr. Heyo Kroemer
Chief executive officer of the Charitè - Universitätsmedizin Berlin
Prof. Dr. Heyo Kroemer
Heyo K. Kroemer (*1960) has been Chief Executive Officer of Charité – Universitätsmedizin Berlin since 2019.
After studying pharmacy, he was appointed Chair of General Pharmacology at the University of Greifswald, later he served as Dean of the Medical Faculty and
Chief Scientific Officer of the University of Greifswald.
From 2012 to 2019, Kroemer was Chairman of the Managing Board of the University Medical Center Göttingen and Dean of the Faculty of Medicine.
He is member of the National Academy of Sciences Leopoldina, of the National Academy of Science and Engineering (acatech) and of the Berlin-Brandenburg Academy of Sciences and Humanities.
Heyo Kroemer chaired the Federal Government’s Corona Expert Council from 2021 to 2023 and until 2025 Expert Council ‘Health and Resilience’.
Dr. Boubou Hallberg
Chief executive officer for Sahlgrenska University Hospital
Dr. Boubou Hallberg
Dr Boubou Hallberg is CEO of Sahlgrenska University Hospital in Göteborg, Sweden, since August 2023. Dr Hallberg is a pediatrician and specialist in neonatology. He has previously served as operations manager and chief physician at Karolinska University Hospital in Stockholm, as well as CEO and vice president in the United Arab Emirates for the healthcare group GHP International.
Prof. Melvin Samsom
Non-executive director Bupa Group Board UK, Senior advisor KPMG Health, Chair Supervisory Board Oncode Institute, professor at Radboudumc The Netherlands
Prof. Melvin Samsom
Non-executive director Bupa Group Board UK, Senior advisor KPMG Health, Chair Supervisory Board Oncode Institute, professor at Radboudumc The Netherlands. Former CEO Karolinska University Hospital, Sweden, former CEO Radboud University Hospital The Netherlands, former Managing Director Health, Wellbeing and Biotech, NEOM, Saudi Arabia
Prof. David Probert
Chief Executive Officer, Univercity College London Hospitals
Prof. David Probert
David became the Chief Executive at UCLH in 2021. Prior to this, David was the Chief Executive of Moorfields Eye Hospital and before that held a number of executive operational and research leadership roles at The Royal Marsden and Guy’s and St Thomas’s NHS Foundation Trusts’. David continues to present on a number of academic and training courses and was recently appointed as a Visiting Professor to the UCLH Global Business School for Health. David is a past Fellow at The Institute of Healthcare Improvement, Boston, USA.
Dr. Carlos Mur de Víu
Director, Psychiatry and Mental Health Services, SAAS, Andorra, Associate Professor, European University (UEM), International Affairs coordinartor, SEDISA
Dr. Carlos Mur de Víu
Born in Zaragoza (Aragón, Spain) in 1976. He holds a Bachelor’s and Doctorate in Medicine and Surgery from the University of Zaragoza, specializing in Psychiatry. Fellow in Psychosomatic Medicine and Consultation-Liaison Psychiatry at Mount Sinai Hospital in New York. Expert in PNIE (Psychoneuroimmunology). Master’s in legal and forensic Psychiatry (UCM) and in Management of Health Institutions (IESE). Master in Integrative Psychotherapy (University of Alcalá). Associate Professor in the Medicine Degree (UAM and European University) and degree in Criminology-Psychology (European University); visiting professor at the University of Alcalá and Harvard University. He has worked as an Consultant psychiatrist and Section Chief at Fundación Jiménez Díaz Hospital in Madrid, as managing director of the Psychiatric Institute of Leganés (2011-2014), and as managing director at Fuenlabrada University Hospital (2014-2019). He has been the scientific coordinator of the Spanish Mental Health Strategy of the SNS for the Ministry of Health. and Director of Social-Health Coordination of the Autonomous Community of Madrid.
He has been a corresponding academic of the Royal Academy of Medicine of Zaragoza since 2014, and an International Distinguished Fellow of the American Psychiatric Association since 2015. He was President of the Spanish Society of Psychosomatic Medicine (SEMP) from 2016 to 2018, and a member of the national board of directors of SEDISA (Spanish Society of Health Executives) since 2016. Author of 4 books, 16 chapters, and more than 200 presentations in national and international media. From September 2020 to October 2021, he was the medical director of CAT Barcelona clinics, specializing in mental disorders and addictions, and a collaborating professor at UIC (International University of Catalonia), as well as a Visiting Senior Lecturer at University College Cork (Ireland). Since November 2021, he has been the director of mental health services in the Principality of Andorra.